IRIS Institutional Research Information System - OPENBS Open Archive UniBS

COLLO, LUIGIA RINALDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.709
AS - Asia 2.600
EU - Europa 2.594
SA - Sud America 560
AF - Africa 39
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
Totale 10.523
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.637
CN - Cina 968
SG - Singapore 890
PL - Polonia 676
UA - Ucraina 597
BR - Brasile 478
IT - Italia 311
DE - Germania 279
HK - Hong Kong 260
FI - Finlandia 167
VN - Vietnam 151
GB - Regno Unito 133
TR - Turchia 101
FR - Francia 97
IE - Irlanda 93
RU - Federazione Russa 93
IN - India 82
CA - Canada 41
AR - Argentina 37
CH - Svizzera 37
BD - Bangladesh 28
BE - Belgio 24
ID - Indonesia 23
AT - Austria 19
EC - Ecuador 18
IQ - Iraq 18
IR - Iran 16
MX - Messico 16
CZ - Repubblica Ceca 14
NL - Olanda 14
ZA - Sudafrica 13
ES - Italia 12
SE - Svezia 12
AU - Australia 11
EU - Europa 9
MA - Marocco 9
CL - Cile 7
JP - Giappone 7
KZ - Kazakistan 7
SA - Arabia Saudita 7
PE - Perù 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
PA - Panama 5
UZ - Uzbekistan 5
CO - Colombia 4
ET - Etiopia 4
JO - Giordania 4
KE - Kenya 4
KR - Corea 4
VE - Venezuela 4
CR - Costa Rica 3
LB - Libano 3
PK - Pakistan 3
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
LT - Lituania 2
LU - Lussemburgo 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
TM - Turkmenistan 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KI - Kiribati 1
LV - Lettonia 1
MY - Malesia 1
OM - Oman 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 10.523
Salva come PNG Salva come JPEG
Città #
Warsaw 675
Woodbridge 481
Fairfield 463
Singapore 442
Jacksonville 436
Ashburn 363
Houston 285
Hong Kong 256
Ann Arbor 240
Cambridge 231
Chandler 229
Beijing 224
Seattle 201
Princeton 177
Wilmington 175
Nanjing 139
New York 114
Dearborn 98
Brescia 96
Dublin 92
Istanbul 85
Los Angeles 71
Helsinki 70
The Dalles 70
Des Moines 65
Nanchang 54
Ho Chi Minh City 52
Munich 51
Buffalo 48
São Paulo 44
Milan 38
Moscow 38
Hebei 37
Jiaxing 37
Shenyang 37
Basel 35
Dong Ket 34
Changsha 32
Tianjin 28
Shanghai 27
Jinan 26
San Francisco 26
San Donà Di Piave 24
London 23
Rio de Janeiro 23
Brussels 21
San Diego 21
Turku 20
Chicago 19
Redondo Beach 19
Dallas 18
Hanoi 18
Santa Clara 17
Toronto 17
Jakarta 16
Pune 16
Lancaster 15
Leawood 15
Hangzhou 14
Hefei 14
Kunming 14
Brooklyn 13
San Mateo 13
Boston 12
Brno 12
Guangzhou 12
Montreal 12
Zhengzhou 12
Boardman 11
Teramo 11
Lanzhou 10
Ningbo 10
Rome 10
Norwalk 9
Phoenix 9
Taizhou 9
Vienna 9
Ardabil 8
Augusta 8
Belo Horizonte 8
Brasília 8
Changchun 8
Charlotte 8
Dhaka 8
Guayaquil 8
Johannesburg 8
Verona 8
Assemini 7
Atlanta 7
Baghdad 7
Curitiba 7
Denver 7
Fuzhou 7
Haikou 7
Manchester 7
Mumbai 7
Poplar 7
Stockholm 7
Tokyo 7
Da Nang 6
Totale 7.110
Salva come PNG Salva come JPEG
Nome #
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling 298
Redistribution of DAT/α-synuclein complexes visualized by “in situ” proximity ligation assay in transgenic mice modelling early Parkinson’s disease 293
Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways 247
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 234
Ketamine enhances structural plasticity in human dopaminergic neurons: Possible relevance for treatment-resistant depression 209
Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation 177
Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels 165
Structural plasticity induced by ketamine in human dopaminergic neurons as mechanism relevant for Treatment-Resistant Depression 159
Pluripotent Stem Cell Based Cultures to Study Key Aspects of Human Cerebral Cortex Development 151
(2 R,6 R)-Hydroxynorketamine promotes dendrite outgrowth in human inducible pluripotent stem cell-derived neurons through AMPA receptor with timing and exposure compatible with ketamine infusion pharmacokinetics in humans 150
Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine 148
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 143
Ketamine increases the expression of GluR1 and GluR2 α-amino-3-hydroxy-5-methy-4-isoxazole propionate receptor subunits in human dopaminergic neurons differentiated from induced pluripotent stem cells 142
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 137
Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugs. 137
A human translational model based on neuroplasticity for pharmacological agents potentially effective in Treatment-Resistant Depression: Focus on dopaminergic system 135
Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling 134
ATP mediated cytotoxicity in microglial cells. 132
An antagonist-insensitive P2X receptor expressed in epithelia and brain 131
P2X1 receptor activation in HL60 cells. 131
Ketamine effects on mammalian target of rapamycin signaling in the mouse limbic system depend on functional dopamine D3 receptors 130
Purinoceptors in the central nervous system 127
Blockade of human P2X7 receptor function with a monoclonal antibody. 126
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment 126
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes 125
The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. 124
The NMDA/D1 receptor complex as a new target in drug development 123
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 122
Tissue distribution of the P2X7 receptor 116
Dopamine D3 receptors are critically involved in the neurotrophic effects of cocaine and nicotine on the mouse mesencephalic dopaminergic neurons 114
P2X receptors: an emerging channel family. 113
Immature neuronal phenotype derived from mouse skin precursor cells differentiated in vitro. 113
Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation. 113
Alpha-synuclein aggregation in dopaminergic cells is modulated by glucose metabolism 111
Critical role of dopamine D3 receptor in structural plasticity generated by exposure to drugs of addiction in mesencephalic dopaminergic neurons 111
In-vivo silencing of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease 110
Alphα6-containing nicotinic acetylcholine receptors mediate nicotine-induced structural plasticity in mouse and human iPSC-derived dopaminergic neurons 109
Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential 109
D3 receptor involvement in neurotrophic effects of amphetamine and cocaine on mesencephalic dopaminergic neurons 108
Distictive functions of a6b4 and other integrins in epithelial cells. 107
Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor. 106
Dopamine D1R activation triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 105
Ketamine produces structural plasticity in dopaminergic neurons via co-activation of MEK-ERK and Akt-mTOR pathways: translation from mouse primary culture to human iPSC-derived neurons 105
Dopamine D3 receptor and beta-2 containing nicotinic acetylcholine receptor are critical in mediating nicotine effects on dopaminergic neurons morphology 104
A new isoform of the laminin receptor α7β1 is developmentally regulated in skeletal muscle. 103
The Shp-2 tyrosine phosphatase interacts with the dopamine D1 receptor and triggers D1-mediated Erk signalling in striatal neurons. 103
Attenuated acute effects of ketamine on mTOR pathway in the limbic system of dopamine D3 receptor knock-out mice 103
CRISPR targeting of human induced pluripotent stem cells (HIPSCS) for lineage tracing of HIPSCS-derived neural stem cells during cortical development in vitro 103
Neurotrophic effects of cocaine on mouse mesencephalic dopaminergic neurons are mediated by dopamine D3 receptors 102
Selective dopaminergic alpha-synuclein pathological changes following glucose deprivation "in vitro": implications for Parkinson's disease 101
Dopamine D1R activation modulates intracellular signalling and triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 100
Role of dopamine D1 receptor and phosphatase Shp-2 in L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. 100
Molecular mechanisms underlying dopamine D1R-dependent activation of striatal Erk1/2 in L-DOPA induced dyskinesia in a rat model of Parkinson’s disease. 100
Cell-type specific integrin variants with alternative α chain cytoplasmic domain 99
Dopamine-induced Erk activation in striatal neurons is mediated by a direct interaction between the D1 receptor and the tyrosine phosphatase Shp-2. 99
Neuroadaptation mechanisms to nicotine in mesencephalic dopaminergic neurons: role of dopamine D3 receptor and nicotinic acetylcholine receptors. 99
Ketamine produces structural plasticity of mouse mesencephalic dopaminergic neurons via activation of Akt-mTOR pathway: role of dopamine D3 receptor. 99
Morphogenetic changes produced by cocaine and nicotine in mesencephalic dopaminergic neurons: role of dopamine D3 receptor 98
Nicotine produces structural plasticity of mesencephalic dopaminergic neurons via activation of Akt-mTor pathway 96
Ketamine produces structural plasticity in dopaminergic neurons in vitro via co-activation of MEK-ERK and Akt-mTOR pathways: role of BDNF and dopamine D3 receptor 95
Differential onset of expression of alpha7 and beta1D integrins during mouse heart and skeletal muscle development. 94
Distinct alpha7A-beta1 and alpha7B-beta1 integrin expression patterns during mouse development: alpha7A is restricted to skeletal muscle but alpha7B is expressed in striated muscle, vasculature, and nervous system. 93
Human iPS cell-derived dopaminergic neurons reveal role for D3 receptors and mTOR in induction of structural plasticity by antiparkinson DA agonists 92
Oxide Nanowires for Neuron Adhesion and Growth 92
Dopamine agonists produce neurotrophic effects on mesencephalic dopaminergic neurons via dopamine D3 receptor activation 90
Knock-down of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of parkinson's disease. 90
Testing the effect of dopamine agonists and of drugs of addiction on structural plasticity of dopaminergic neurons: translation from mouse primary cell culture to human iPSC-derived neurons 90
The integrin alpha6beta4 in epithelial and carcinoma cells 89
Evidence for soluble Interleukin-2 receptor (IL-2) as immunosuppressive factor. 86
Nicotine enhances the neuroplasticity of dopamine neurons: role of dopamine D3 receptors and acetylcholine nicotinic receptors. 86
Testing drugs for structural plasticity in dopaminergic neurons: translation from mouse primary cell culture to human iPSC-derived neurons 86
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs). 85
Gradient of integrin α6A expession in the myocardium during early heart development. 84
Effetti neurotrofici dei farmaci agonisti preferenziali D3 sui neuroni mesencefalici: implicazioni terapeutiche per la malattia di Parkinson. 82
Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings 82
Myogenic conversion of NIH3T3 cells by exogenous MyoD family members: dissociation of terminal differentiation from myotube formation. 81
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques 81
Long-term expansion of dopaminergic progenitors from human induced pluripotent stem cells (iPSCs) and differentiation into dopaminergic neurons in vitro and in vivo 80
Loss of Synaptic D1 Dopamine/N-Methyl-D-aspartate Glutamate Receptor Complexes in L-DOPA-Induced Dyskinesia in the Rat. 78
Neuroprotective effects of D2/D3 agonists in an "in vitro" model of dopaminergic degeneration 78
Dopamine D3 receptors mediate the neurotrophic effects of dopaminergic agonists on mesencephalic dopaminergic neurons. 78
Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro. 77
Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. 75
Nicotine enhances structural plasticity in mesencephalic dopaminergic neurons: involvement of dopamine D3 receptors and nicotinic acetylcholine receptors. 75
Dopamine D3 receptors mediate the neurotrophic effects of dopaminergic agonists on mesencephalic dopaminergic neurons 74
Downregulation of dopamine D1/NMDA receptor complexes in the post synaptic densities of dyskinetic rats 72
The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. 71
Involvement of nicotinic acetylcholine receptors and dopamine D3 receptors in structural plasticity of dopaminergic neurons 71
Meccanismo molecolari e cellulari nel Morbo di Parkinson 70
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs) 68
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs). 65
Nicotine produces neurotrophic effects on mesencephalic dopaminergic neurons: role of dopamine D3 receptors and nicotinic acetylcholine receptors 65
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 63
Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist 61
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 57
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 55
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 45
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs) 44
Involvement of DA D3 Receptors in Structural Neuroplasticity of Selected Limbic Brain Circuits: Possible Role in Treatment-Resistant Depression 40
Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist d-serine 39
Totale 10.794
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.013
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021895 0 0 0 0 0 136 61 151 180 121 189 57
2021/2022667 62 140 4 18 9 19 30 43 30 75 54 183
2022/2023627 93 3 10 54 57 187 4 64 106 0 15 34
2023/2024651 41 10 52 53 32 147 28 23 131 17 14 103
2024/20251.762 2 40 24 253 157 118 135 35 240 165 367 226
2025/20261.721 320 433 214 411 307 36 0 0 0 0 0 0
Totale 10.895